v3.26.1
Condensed Consolidated Interim Statements of Cash Flows
 9 Months Ended 12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Mar. 31, 2025
USD ($)
Mar. 31, 2024
USD ($)
OPERATING ACTIVITIES        
Net loss $ (24,982,562) $ (34,274,476) $ (42,992,724) $ (52,093,659)
Adjustments to reconcile net losses to net cash used in operating activities:        
Depreciation 70,408 138,088 172,425 261,747
Interest due from related parties loan (2,369) (2,369) (3,144)
Fair value gain on derivative liability (546,121)
Foreign exchange effect on convertible debenture 204,694
Provision for legal claim 692,009 (848,213) 9,921,298
Provision for contract settlement     1,252,076
Provision for losses on related party transactions 479,809 479,808 1,872,334
Accretion expense 3,155 719,195 203,918
Interest expense 25,291 545,000 1,953,499 348,441
Issuance of shares for advisory units 49,714    
Provision for contract settlement 1,252,076    
Issuance of advisory Units and warrants for services     49,714 61,049
Restricted shares units (3,300,231)
Share based payments 5,336,681 8,855,582 7,679,205 7,850,119
Changes in operating assets and liabilities:        
Accounts receivable (164,000) 100,000 100,000 (65,000)
Contract assets and unbilled revenue 6,654 (242,959) (6,654) 98,359
Provision for legal claim (1,791,000)    
Tax receivable (157,050) (182,822) (229,948) (170,149)
Prepaid expenses (469,725) (58,082) 158,287 648,326
Deferred financing costs 118,546 80,993 (37,553) (80,993)
Legal claim payments     (125,000)
Accounts payable and accrued liabilities 1,134,893 289,726 (792,865) 1,615,703
Deferred revenue (100,000) 100,000 100,000 (65,000)
Net cash used in operating activities (21,788,300) (24,762,761) (33,091,087) (29,593,507)
INVESTING ACTIVITIES        
Due from related parties     (479,808) (1,070,582)
Investment in equipment (65,285) (30,580) (30,579) (185,155)
Net cash used in investing activities (65,285) (30,580) (510,387) (1,255,737)
FINANCING ACTIVITIES        
Deferred grant (25,993) 122,748 67,732
Proceeds from issuance of contingent consideration 495,880    
Contingent consideration issuance costs (50,037)    
Repayments of loans (1,938) (2,005,815) (2,007,106) (7,752)
Proceeds from issuance of special warrants 8,511,105
Special warrant issuance costs    
Proceeds from issuance of promissory notes     2,000,000
Proceeds from issuance of equity instruments 1,572,440 2,017,805 2,951,695 9,839,457
Proceeds from issuance of Units 14,930,232 6,690,340 29,272,271 17,518,269
Units issuance costs (1,759,795) (515,276)    
Special warrant issuance costs (372,877) (446,682)
Private placement issuance costs     (2,179,478) (1,697,576)
Proceeds from issuance of convertible debentures 1,934,170 10,000,000 10,000,000
Convertible debentures issuance costs (69,527)   (446,682)
Lease payments     (113,978)
Net cash provided by financing activities 17,025,432 24,448,030 37,658,432 27,538,420
Foreign exchange effect on cash 79,201 329,535 (132,779) (193,730)
Net change in cash during the period (4,748,952) (15,776) 3,924,179 (3,504,554)
Cash, beginning of the period 4,816,906 892,727 892,727 4,397,281
Cash, end of the period $ 67,954 $ 876,951 $ 4,816,906 $ 892,727